I agree that this site is using cookies. You can find further informations here.
X
Atasoy, Ajlan
27  results:
Search for persons X
?
1

Postoperative Chemotherapy Use and Outcomes From ADAURA: Os..:

Wu, Yi-Long ; John, Thomas ; Grohe, Christian...
Journal of Thoracic Oncology.  17 (2022)  3 - p. 423-433 , 2022
Link: https://doi.org/10.1016/..
 
?
2

A Plain Language Summary of Results From the ADAURA Study: ..:

Wu, Yi-Long ; Tsuboi, Masahiro ; John, Thomas...
Future Oncology.  17 (2021)  35 - p. 4827-4835 , 2021
Link: https://doi.org/10.2217/..
 
?
3

Improving Clinical Trial Design in Gastrointestinal Oncolog:

, In: Textbook of Gastrointestinal Oncology,
Atasoy, Ajlan ; Mauer, Murielle - p. 493-507 , 2019
Link: https://doi.org/10.1007/..
 
?
4

Safety of Nivolumab plus Low-Dose Ipilimumab in Previously ..:

Morse, Michael A. ; Overman, Michael J. ; Hartman, Leighanne...
The Oncologist.  24 (2019)  11 - p. 1453-1461 , 2019
Link: https://doi.org/10.1634/..
 
?
5

Phase II Study of Irinotecan Plus Panitumumab as Second-Lin..:

Yoon, Harry ; Karapetyan, Lilit ; Choudhary, Anita...
The Oncologist.  23 (2018)  9 - p. 1004-e102 , 2018
Link: https://doi.org/10.1634/..
 
?
6

Lapatinib with ECF/X in the first-line treatment of metasta..:

the EORTC Gastrointestinal Tract Cancer Group ; Moehler, Markus ; Schad, Arno...
Cancer Chemotherapy and Pharmacology.  82 (2018)  4 - p. 733-739 , 2018
Link: https://doi.org/10.1007/..
 
?
7

Core Clinical Data Elements for Cancer Genomic Repositories..:

Conley, Robert B. ; Dickson, Dane ; Zenklusen, Jean Claude...
Cell.  171 (2017)  5 - p. 982-986 , 2017
Link: https://doi.org/10.1016/..
 
?
8

Impact of Oncotype DX Recurrence Score on Treatment Decisio..:

Ozmen, Vahit ; Atasoy, Ajlan ; Gokmen, Erhan...
Cureus.  , 2016
Link: https://doi.org/10.7759/..
 
?
9

Hypersensitivity and Tumor Lysis Syndrome Associated with C..:

Cihan, Sener ; Atasoy, Ajlan ; Yildirim, Yasar..
Tumori Journal.  101 (2015)  2 - p. e40-e45 , 2015
Link: https://doi.org/10.5301/..
 
?
10

Prognostic value of receptor status change following neoadj..:

Ozmen, Vahit ; Atasoy, Ajlan ; Bozdogan, Atilla...
Cancer Treatment Communications.  4 (2015)  - p. 89-95 , 2015
Link: https://doi.org/10.1016/..
 
?
11

Barrett's esophagus and animal models:

Macke, Ryan A. ; Nason, Katie S. ; Mukaisho, Ken‐ichi...
Annals of the New York Academy of Sciences.  1232 (2011)  1 - p. 392-400 , 2011
Link: https://doi.org/10.1111/..
 
?
12

Barrett's esophagus: treatments of adenocarcinomas I:

Komanduri, Srinadh ; Deprez, Pierre H. ; Atasoy, Ajlan...
Annals of the New York Academy of Sciences.  1232 (2011)  1 - p. 248-264 , 2011
Link: https://doi.org/10.1111/..
 
?
13

Impact Of Oncotype Dx Recurrence Score On Treatment Decisio..:

Ozmen, Vahit ; Atasoy, Ajlan ; Gokmen, Erhan...
10.7759/cureus.522.  , 2019
Link: http://hdl.handle.net/11..
 
?
14

Safety of Nivolumab plus Low‐Dose Ipilimumab in Previously ..:

Morse, Michael A ; Overman, Michael J ; Hartman, Leighanne...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853093/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
15

Phase II Study of Irinotecan Plus Panitumumab as Second‐Lin..:

Yoon, Harry ; Karapetyan, Lilit ; Choudhary, Anita...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192615/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
1-15